Jean-Paul De La O

The acinar differentiation determinant PTF1A inhibits initiation of pancreatic ductal adenocarcinoma

Michael R Green, Michael R. Green, M. Bronner, 2015, eLife.

Notch and Kras in pancreatic cancer: At the crossroads of mutation, differentiation and signaling

L. C. Murtaugh, Jean-Paul De La O, J. De La O, 2009, Cell cycle.

β-catenin is selectively required for the expansion and regeneration of mature pancreatic acinar cells in mice

M. Keefe, L. C. Murtaugh, Ameena Y. Khan, 2012, Disease Models & Mechanisms.

Preclinical Efficacy of Ron Kinase Inhibitors Alone and in Combination with PI3K Inhibitors for Treatment of sfRon-Expressing Breast Cancer Patient-Derived Xenografts

A. Welm, M. Bieniasz, Jean-Paul De La O, 2015, Clinical Cancer Research.

What is the Cell of Origin for Pancreatic Cancer?

L. C. Murtaugh, Jean-Paul De La O, 2009 .

Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia

J. L. Goodman, L. C. Murtaugh, L. Emerson, 2008, Proceedings of the National Academy of Sciences.

RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer

D. Chan, M. Ellis, S. Fuqua, 2020, British journal of cancer.

Notch signaling: where pancreatic cancer and differentiation meet?

L. C. Murtaugh, Jean-Paul De La O, L. Murtaugh, 2009, Gastroenterology.